Pyflubumide
CAS: 926914-55-8
Ref. 3D-BMB91455
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
- 1,3,5-Trimethyl-N-(2-methyl-1-oxopropyl)-N-[3-(2-methylpropyl)-4-[2,2,2-trifluoro-1-methoxy-1-(trifluoromethyl)ethyl]phenyl]-1H-pyrazole-4-carboxamide
- N-[3-Isobutyl-4-[2,2,2-trifluoro-1-methoxy-1-(trifluoromethyl)ethyl]phenyl]-N-isobutyryl-1,3,5-trimethyl-pyrazole-4-carboxamide
- 1H-Pyrazole-4-carboxamide, 1,3,5-trimethyl-N-(2-methyl-1-oxopropyl)-N-[3-(2-methylpropyl)-4-[2,2,2-trifluoro-1-methoxy-1-(trifluoromethyl)ethyl]phenyl]-
Pyflubumide is an analog of a medicinal compound that has been shown to have potent anticancer properties. It works by inhibiting kinases, which are enzymes that play a key role in the growth and proliferation of cancer cells. Pyflubumide induces apoptosis, or programmed cell death, in human tumor cells and has been shown to be effective against a range of different types of cancer. This inhibitor has been extensively studied in Chinese hamster ovary cells and has demonstrated significant antitumor activity both in vitro and in vivo. Pyflubumide is excreted primarily via urine, making it an attractive candidate for further development as a potential anticancer drug.
Propiedades químicas
Consulta técnica sobre: 3D-BMB91455 Pyflubumide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
